TCTME+

#2025 is the beginning of an era 💡Innovation 💡Collaboration 💡Education Highlights: 🖌️450 faculty & presenters from all 5 continents 🖌️>3000 registrants 🖌️iCOACH, wet-lab & Silent hall most popular Awards: 🏆Travel & Research @wmahmeed 🏆 @MYFegy 🏆@JACCJournals 🏆Best case

Morbidly obese (surgical turndown) with symptomatic severe AS LCA height of 7.7 mm What’s your plan for coronary protection? @aelsab @CathElectroSurg @RodrigoBagur @LouaiRazzouk @MCoylewright @mathur_a @HindAlosaimi_ @TCT_ME_ @TAVRBot

Another great @CictTherapy led by @IssamDMoussa1 with @amrmohsen213 and @DrAFrangieh excellent topics and world class faculty. Looking forward to next year @BeaumontCards @CorewellHealth

🚨 Just one week away! #TCTPlusIndia2025 is bringing global expertise and breakthrough innovations to the heart of New Delhi. Explore the Program Guide & start planning your experience now: ow.ly/lz0A50WrBLM @BurkhoffMd @djc795 @georgedangas @jgranadacrf @MartyBLeon…

It will be a very special edition. Just remember that. It will break major records. 🚨🚨🚨🚨🚨🚨🚨🚨🚨

Building on 2025 #TCTPlusMiddleEast in its second iteration brings novelty to you…tell us what ideas you have in mind & we will deliver @crfheart @TCTConference @jgranadacrf @mirvatalasnag @drptca @AlkashkariWail @kfaraidy @mmamas1973 @triciarawh

📢 Good news! The abstracts deadline for #TCT2025 has been extended to July 16! This is your chance to share your science with the world and become a part of the prestigious TCT faculty! ⏰The clock’s ticking. Make it count! tctconference.com/topics-categor… #CardioX #CardioTwitter…

Nurses, Techs, and allied health professionals— take advantage of this new opportunity to present an interesting case (coronary, structural, vascular) at TCT. A great opportunity to showcase your work and educate your colleagues!

Honored to serve as faculty at this year’s amazing #NYValves2025, the world’s leading Structural Heart meeting! Three days filled with cutting-edge innovation, meaningful discussions, and educational excellence. I was grateful for the opportunity to share some of our work from…

We're on Day 2 of #NYValves2025 with late-breaking clinical trials, live cases, and more! Access the latest content from this year's structural heart conference in NYC on TCTMD: tctmd.com/nyvalves2025

Absolutely…this team is just warming up 😎..2️⃣0️⃣2️⃣6️⃣ @crfheart @TCTConference @jgranadacrf @MartyBLeon @hahn_rt @PhilGenereuxMD @triciarawh @kfaraidy @AlkashkariWail @drptca @mmamas1973

If you thought ②⓪②⑤ was something..wait for ❷ʘ➁❻..preparations are underway 🗓️ Mark your calendars 🗓️ April 9-11, 2026 - Riyadh, Saudi Arabia 🇸🇦 @crfheart @TCTConference @MartyBLeon @jgranadacrf @mirvatalasnag @drptca @HindAlosaimi_ @triciarawh

@crfheart #NYValves2025 Global & Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies 🔹Are we doing better treating structural heart disease than CAD? 🔹Have transcatheter therapies allowed better care? 🔹Low income…

@crfheart #NYValves2025 #LBCT 2-yr Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study @GilbertTangMD 🔹No device-related deaths, disabling strokes, or reinterventions 🔹Improvements in stroke volume, CO, RV…

First-in-Human report presented at #NYValves2025 with a #simpub in @JACCJournals #JACCCR The @bostonsci #LOTUS valve was a mechanically expanded THV with a low profile. ViV-TAVR inside #Lotus has previously been successful using both SEVs & BEV’s, with low risk of coronary…

Exciting to see several sessions on endocarditis at #NYValves2025 always on the cutting edge of structural innovation. Join the discussion on this evolving frontier in valve and infection management @sanjum @HamidNadira @crfheart @TCT_ME_ @mirvatalasnag @kashishgoelmd @jtsaxon

This is an open invitation to the presenters to submit your work to @SaudiMedJ @alamrymd @AlhazzaniW Impressive data 🔹 Men experienced a significantly higher incidence of the composite primary endpoint of all-cause mortality, HF hospitalization, or reintervention 🔹 IPT…

Ready steady go…@Drroxmehran @HindAlosaimi_ @crfheart @TCT_ME_

#NYValves2025 @crfheart This was interesting data. We ought to remember: 1) surgeons getting better with explants 2) TAVR failure at 3yr suggests initial implant was suboptimal (eg significant PVL) which cannot be corrected with another TAVR 3) These data excluded endocarditis…

Looking forward to more simulation based iCOACH sessions in 2026 @drptca @kfaraidy @mmamas1973 @AlkashkariWail @ASE360 @Heart_SCCT

Tips from #NYValves2025 @crfheart @TCTConference New concept: Instead of chasing the device, set crosshair targets for the operator to aim for..allows one to maintain coaxial position @azeemlatib @jgranadacrf @drptca @mirvatalasnag @AlkashkariWail @mmamas1973 @kfaraidy